A comparative result of ventriculoperitoneal shunt, focusing mainly on gravity-assisted valve and programmable valve
- PMID: 21082054
- PMCID: PMC2966728
- DOI: 10.3340/jkns.2010.48.3.251
A comparative result of ventriculoperitoneal shunt, focusing mainly on gravity-assisted valve and programmable valve
Abstract
Objective: Despite rapid evolution of shunt devices, the complication rates remain high. The most common causes are turning from obstruction, infection, and overdrainage into mainly underdrainage. We investigated the incidence of complications in a consecutive series of hydrocephalic patients.
Methods: From January 2002 to December 2009, 111 patients underwent ventriculoperitoneal (VP) shunting at our hospital. We documented shunt failures and complications according to valve type, primary disease, and number of revisions.
Results: Overall shunt survival time was 268 weeks. Mean survival time of gravity-assisted valve (GAV) was 222 weeks versus 286 weeks for other shunts. Survival time of programmable valves (264 weeks) was longer than that of pressure-controlled valves (186 weeks). The most common cause for shunt revision was underdrainage (13 valves). The revision rate due to underdrainage in patients with GAV (7 of 10 patients) was higher than that for other valve types. Of 7 patients requiring revision for GAV underdrainage, 6 patients were bedridden. The overall infection rate was 3.6%, which was lower than reported series. Seven patients demonstrating overdrainage had cranial defects when operations were performed (41%), and overdrainage was improved in 5 patients after cranioplasty.
Conclusion: Although none of the differences was statistically significant, some of the observations were especially notable. If a candidate for VP shunting is bedridden, GAV may not be indicated because it could lead to underdrainage. Careful procedure and perioperative management can reduce infection rate. Cranioplasty performed prior to VP shunting may be beneficial.
Keywords: Complication; Gravity-assisted valve; Hydrocephalus; Shunt; Survival time.
Figures



Similar articles
-
Experiences with a gravity-assisted valve in hydrocephalic children. Clinical article.J Neurosurg Pediatr. 2009 Sep;4(3):289-94. doi: 10.3171/2009.4.PEDS08204. J Neurosurg Pediatr. 2009. PMID: 19772417
-
The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.Pediatr Neurosurg. 2005 Jan-Feb;41(1):8-14. doi: 10.1159/000084859. Pediatr Neurosurg. 2005. PMID: 15886507 Clinical Trial.
-
Comparative durability and costs analysis of ventricular shunts.J Neurosurg. 2018 May 11;130(4):1252-1259. doi: 10.3171/2017.11.JNS172212. Print 2019 Apr 1. J Neurosurg. 2018. PMID: 29749912
-
Shunt Devices for the Treatment of Adult Hydrocephalus: Recent Progress and Characteristics.Neurol Med Chir (Tokyo). 2016 May 15;56(5):274-83. doi: 10.2176/nmc.ra.2015-0282. Epub 2016 Apr 4. Neurol Med Chir (Tokyo). 2016. PMID: 27041631 Free PMC article. Review.
-
Hydrocephalus and Ventriculoperitoneal Shunts: Modes of Failure and Opportunities for Improvement.Crit Rev Biomed Eng. 2016;44(1-2):91-7. doi: 10.1615/CritRevBiomedEng.2016017149. Crit Rev Biomed Eng. 2016. PMID: 27652453 Review.
Cited by
-
The hydrokinetic parameters of shunts for hydrocephalus might be inadequate.Surg Neurol Int. 2012;3:40. doi: 10.4103/2152-7806.94292. Epub 2012 Mar 24. Surg Neurol Int. 2012. PMID: 22530174 Free PMC article.
-
Analysis of the potential risk of central intravenous lines and/or total parenteral nutrition with ventriculoatrial shunts.Childs Nerv Syst. 2015 Apr;31(4):563-8. doi: 10.1007/s00381-015-2656-z. Epub 2015 Feb 25. Childs Nerv Syst. 2015. PMID: 25712743
-
Long-term follow-up and comparison of programmable and non-programmable ventricular cerebrospinal fluid shunts among adult patients with different hydrocephalus etiologies: a retrospective cohort study.Acta Neurochir (Wien). 2023 Sep;165(9):2551-2560. doi: 10.1007/s00701-023-05734-z. Epub 2023 Aug 9. Acta Neurochir (Wien). 2023. PMID: 37553445 Free PMC article.
-
Role of ventriculoperitoneal shunt valve design in the treatment of pediatric hydrocephalus--a single center study of valve performance in the clinical setting.Childs Nerv Syst. 2014 Feb;30(2):293-7. doi: 10.1007/s00381-013-2244-z. Epub 2013 Jul 31. Childs Nerv Syst. 2014. PMID: 23900632
-
Shunt-responsive idiopathic normal pressure hydrocephalus patient with delayed improvement after tap test.J Korean Neurosurg Soc. 2013 Nov;54(5):437-40. doi: 10.3340/jkns.2013.54.5.437. Epub 2013 Nov 30. J Korean Neurosurg Soc. 2013. PMID: 24379955 Free PMC article.
References
-
- Ahn ST, Yoo DS, Cho KS, Kim JK, Huh PW, Kim DS, et al. The use of the programmable valve shunt system in the management of patients with hydrocephalus. J Korean Neurosurg Soc. 2002;31:139–144.
-
- Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, et al. Dutch Normal-Pressure Hydrocephalus Study : randomized comparison of low- and medium-pressure shunts. J Neurosurg. 1998;88:490–495. - PubMed
-
- Czosnyka Z, Czosnyka M, Richards HK, Pickard JD. Posture-related overdrainage : comparison of the performance of 10 hydrocephalus shunts in vitro. Neurosurgery. 1998;42:327–333. discussion 333-334. - PubMed
-
- Dauch WA, Zimmermann R. [Normal pressure hydrocephalus. An evaluation 25 years following the initial description] Fortschr Neurol Psychiatr. 1990;58:178–190. - PubMed
LinkOut - more resources
Full Text Sources